>
NonConformist Series: Practical Wealth - Join us virtually Dec 29-30, 2025
New bill would allow private citizens to fight cartels: 'WE ARE UNDER ATTACK'
Carnivore Got Me 90% There. This One Drink Changed Everything
Perfect Aircrete, Kitchen Ingredients.
Futuristic pixel-raising display lets you feel what's onscreen
Cutting-Edge Facility Generates Pure Water and Hydrogen Fuel from Seawater for Mere Pennies
This tiny dev board is packed with features for ambitious makers
Scientists Discover Gel to Regrow Tooth Enamel
Vitamin C and Dandelion Root Killing Cancer Cells -- as Former CDC Director Calls for COVID-19...
Galactic Brain: US firm plans space-based data centers, power grid to challenge China
A microbial cleanup for glyphosate just earned a patent. Here's why that matters
Japan Breaks Internet Speed Record with 5 Million Times Faster Data Transfer

"Technocracy is the science of social engineering," says Patrick Wood, author of Technocracy Rising.
Social engineering used to mean molding the minds of people to conform to new norms. This goes back to 1928, Ed Bernays, and his book Propaganda. However, in a Technocracy, not only minds, but bodies, too, can be molded. If you did not get the memo, Technocracy has brought humanity from Human to Posthuman and Transhuman.
In the 2022 Journal Global Trends, Russian scientists describe the difference between Posthuman and Transhuman:
The fundamental idea of posthumanism is the rejection of biological, ethical, and ontological anthropocentrism. Transhumanism focuses on changing and improving natural human characteristics through biological, technological, and cognitive modifications…Transhumanism has the potential to preserve man as an effective economic and cognizing agent.
In other words, man as an "economic agent" refers to the cybernetic human as a commodity in a modern world. This means the laws of the nations need to change to catch up.
The U.S. FDA is meeting that goal for change with its FDA Modernization Act 2.0. What is the FDA Modernization Act 2.0?
The new law amends the Federal Food, Drug, and Cosmetic Act by authorizing sponsors of novel drugs to make use of "certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.